Search Results 1041-1050 of 17175 for treatment resistant depression
... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...
... treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL) ...
... treatment of patients who have chronic lymphocytic leukemia that has returned or is resistant to treatment. Participation eligibility. Participant ...
Research suggests that the growth of new blood vessels to the tumor plays a significant role in chemotherapy drug resistance. Dr. Copland is studying the ...
... treatment options for a wide range of diseases. ... resistance in ovarian, breast, pancreatic and ... treat Alzheimer's disease. If a team does not ...
... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is a ...
... resistant to therapy. These activities are a first step toward identifying alternative therapies and subsequently beginning to personalize the therapy for ...
The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ( ...
The purpose of this study is to compare, in a non-inferiority fashion, the progression-free survival (PFS) in patients with metastatic refractory ...
This study examined psychosocial factors, such as drug use, depression and nonsmoking status to determine if they are associated with higher ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.